Back to Journals » Lung Cancer: Targets and Therapy » Volume 4

Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy

Total article views   HTML views PDF downloads Totals
10,059 Dovepress* 9,103+ 1,621 10,724
PubMed Central* 956 94 1,050
Totals 10,059 1,715 11,774
*Since 10 June 2013
+Since July 2016

View citations on PubMed Central and Google Scholar